Business / Finance

RSS

Adcare Health Systems prices underwritten public offering of Series A Preferred Stock

AdCare Health Systems, Inc. the "Company") announced today that it has priced a "best efforts" underwritten public offering of its 10.875% Series A Cumulative Redeemable Preferred Stock (the "Series A Preferred Stock") at a public offering price of $25.00 per share.

24 Oct 2013

Life Time Fitness' revenues increase 7.2% to $316M in third quarter 2013

Life Time Fitness, Inc., The Healthy Way of Life Company, today reported its financial results for the third quarter ended September 30, 2013.

24 Oct 2013

McKesson’s revenues increase 11% to $33B in second quarter 2014

McKesson Corporation (NYSE:MCK) today reported that revenues for the second quarter ended September 30, 2013 were $33 billion, up 11% compared to $29.8 billion a year ago. On the basis of U.S. generally accepted accounting principles ("GAAP"), second-quarter earnings per diluted share was $1.74 compared to $1.67 a year ago.

24 Oct 2013

The Wellness Network announces acquisition of LOGICARE

The Wellness Network, parent company of The Patient Channel, The Newborn Channel, and HealthStyle Press, today announced that it has acquired LOGICARE Corporation, a leading hospital patient education software company.

24 Oct 2013

Zimmer Holdings net sales increase 4.8% to $1.07 billion in Q3 2013

Zimmer Holdings, Inc. today reported financial results for the quarter ended September 30, 2013. The Company reported third quarter net sales of $1.07 billion, an increase of 4.8% reported and 6.7% constant currency over the third quarter of 2012

24 Oct 2013

Amedica signs distribution agreement with K2M

Amedica Corporation, a biomaterial company, announced today that it has entered into a distribution agreement with K2M that will provide surgeons and hospitals in Europe with access to Amedica's Silicon Nitride interbody spinal fusion devices.

24 Oct 2013

ICON Q3 net revenues increase 19% to $339.8 million

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the third quarter ended September 30, 2013.

24 Oct 2013

MedRisk acquires Medical Diagnostic Associates Management

MedRisk, Inc., the nation's leading provider of physical medicine management to the workers' compensation industry, has acquired Medical Diagnostic Associates Management, Inc. based in Calabasas, Calif., and its access to a national diagnostic imaging network.

24 Oct 2013

McKesson agrees to acquire majority stake in Celesio

McKesson Corporation, a leading North American healthcare services and information technology company, and Celesio AG, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, announced today that McKesson has signed an agreement to acquire a majority stake in Celesio for €23 per share and to launch parallel voluntary public tender offers for the remaining publicly-traded shares and outstanding convertible bonds of Celesio.

24 Oct 2013

MEDICREA records over 60% of sales in third quarter 2013

The MEDICREA Group, which specializes in the development of innovative surgical technologies for the treatment of spinal pathologies, listed on Alternext by NYSE - Euronext Paris, announces its sales for the third quarter of 2013, ended September 30.

23 Oct 2013

Accelera Innovations, Lambert Private Equity sign Investment Agreement to support growth initiatives

Accelera Innovations, Inc. a Chicago-based healthcare software-as-a-service provider (the "Company") today announced it has entered into a Standby Equity Purchase Agreement ("Investment Agreement") with Lambert Private Equity, LLC, (the "Investor").

23 Oct 2013

Imugene Acquiring Biolife, As Lead Pipeline Candidate Nears Phase II

...

23 Oct 2013

Cleveland Biolabs Subsidiary Awarded $4.6M Russian Contract

...

23 Oct 2013

Startup Wins Five-Year Exclusive License To Decode Genetics Platform

...

23 Oct 2013

CoLucid signs distribution and supply agreement with ILDONG for Lasmiditan

CoLucid Pharmaceuticals, Inc., and ILDONG Pharmaceutical Co., Ltd., announced today that they have entered into a distribution and supply agreement for Lasmiditan in South Korea and Southeast Asia.

23 Oct 2013

Orygen To Manufacture Epirus' Remicade Biosimilar In Brazil

...

22 Oct 2013

Amgen Buys Roche Rights To Neutropenia Drugs

...

22 Oct 2013

Novozymes, Almac Ally To Offer Drug Targeting, Pharmacokinetics Service

...

22 Oct 2013

PDL Biopharma Acquires Diabetes Royalty, Milestone Rights For $240.5M

...

22 Oct 2013

diaDexus amends agreement with Comerica Bank to expand existing loan facility

diaDexus, Inc., a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that it has amended its agreement with Comerica Bank to expand its existing loan facility from $5 million to $10 million.

22 Oct 2013